A large body of research has demonstrated the beneficial effects of NRF2 activation in several NAFLD and NASH related clinical metrics including hepatic steatosis, inflammation, and insulin resistance (33). The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.